SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Dijkshoorn L., Nemec A., Seifert H. (2007) An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol 5: 93951.
  • 2
    Peleg A.Y., Seifert H., Paterson D.L. (2008) Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 21: 53882.
  • 3
    Euzéby J.P. List of prokaryotic names with standing in nomenclature-genus Acinetobacter. [Cited June 2013] Available from URL: http://www.bacterio.cict.fr/a/acinetobacter.html.
  • 4
    Turton J.F., Shah J., Ozongwu C., Pike R. (2010) Incidence of Acinetobacter species other than A. baumannii among clinical isolates of Acinetobacter: evidence for emerging species. J Clin Microbiol 48: 14459.
  • 5
    Kuo S.C., Fung C.P., Lee Y.T., Chen C.P., Chen T.L. (2010) Bacteremia due to Acinetobacter genomic species 10. J Clin Microbiol 48: 58690.
  • 6
    Rodriguez-Baño J., Martí S., Ribera A., Fernández-Cuenca F., Dijkshoorn L., Nemec A., Pujol M., Vila J. (2006) Nosocomial bacteremia due to an as yet unclassified Acinetobacter genomic species 17-like strain. J Clin Microbiol 44: 15879.
  • 7
    Dortet L., Legrand P., Soussy C.J., Cattoir V. (2006) Bacterial identification, clinical significance, and antimicrobial susceptibilities of Acinetobacter ursingii and Acinetobacter schindleri, two frequently misidentified opportunistic pathogens. J Clin Microbiol 44: 44718.
  • 8
    Gundi V.A., Dijkshoorn L., Burignat S., Raoult D., La Scola B. (2009) Validation of partial rpoB gene sequence analysis for the identification of clinically important and emerging Acinetobacter species. Microbiology 155: 233341.
  • 9
    La Scola B., Gundi V.A., Khamis A., Raoult D. (2006) Sequencing of the rpoB gene and flanking spacers for molecular identification of Acinetobacter species. J Clin Microbiol 44: 82732.
  • 10
    Kishii K., Kikuchi K., Matsuda N., Yoshida A., Okuzumi K., Uetera Y., Yasuhara H., Moriya K. (2013) Evaluation of matrix-assisted laser desorption ionization-time of flight mass spectrometry for species identification of Acinetobacter strains isolated from blood cultures. Clin Microbiol Infect doi: 10.1111/1469-0691.12376 [Epub ahead of print]
  • 11
    Turton J.F., Ward M.E., Woodford N., Kaufmann M.E., Pike R., Livermore D.M., Pitt T.L. (2006) The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS Microbiol Lett 258: 727.
  • 12
    Clinical and Laboratory Standards Institute. (2010) Performance standards for antimicrobial susceptibility testing: twentieth informational supplement M100-S20. CLSI, Wayne, PA, USA.
  • 13
    Espinal P., Fugazza G., López Y., Kasma M., Lerman Y., Malhotra-Kumar S., Goossens H., Carmeli Y., Vila J. (2011) Dissemination of an NDM-2-producing Acinetobacter baumannii clone in an Israeli rehabilitation center. Antimicrob Agents Chemother 55: 53968.
  • 14
    Poirel L., Nordmann P. (2006) Genetic structures at the origin of acquisition and expression of the carbapenem-hydrolyzing oxacillinase gene blaOXA-58 in Acinetobacter baumannii. Antimicrob Agents Chemother 50: 14428.
  • 15
    Higgins P.G., Pérez-Llarena F.J., Zander E., Fernández A., Bou G., Seifert H. (2013) OXA-235, a novel class D β-lactamase involved in resistance to carbapenems in Acinetobacter baumannii. Antimicrob Agents Chemother 57: 21216.
  • 16
    Notake S., Matsuda M., Tamai K., Yanagisawa H., Hiramatsu K., Kikuchi K. (2013) Detection of IMP metallo-β-lactamase in carbapenem-non-susceptible Enterobacteriaceae and glucose non-fermenting gram-negative rods by immunochromatography assay. J Clin Microbiol 51: 17628.
  • 17
    Vila J., Ruiz J., Goñi P., Marcos A., Jimenez de Anta T. (1995) Mutation in the gyrA gene of quinolone-resistant clinical isolates of Acinetobacter baumannii. Antimicrob Agents Chemother 39: 12013.
  • 18
    Vila J., Ruiz J., Goñi P., Jimenez de Anta T. (1997) Quinolone-resistance mutations in the topoisomerase IV parC gene of Acinetobacter baumannii. J Antimicrob Chemother 39: 75762.
  • 19
    Vaneechoutte M., De Baere T., Nemec A., Musílek M., van der Reijden T.J., Dijkshoorn L. (2008) Reclassification of Acinetobacter grimontii Carr et al. 2003 as a later synonym of Acinetobacter junii Bouvet and Grimont 1986. Int J Syst Evol Microbiol 58: 93740.
  • 20
    Loubinoux J., Mihaila-Amrouche L., Le Fleche A., Pigne E., Huchon G., Grimont P.A., Bouvet A. (2003) Bacteremia caused by Acinetobacter ursingii. J Clin Microbiol 41: 13378.
  • 21
    Kumar S.S., Vengadassalapathy L., Menon T. (2008) Prosthetic valve endocarditis caused by Acinetobacter baumannii complex. Indian J Pathol Microbiol 51: 573.
  • 22
    Starakis I., Blikas A., Siagris D., Marangos M., Karatza C., Bassaris H. (2006) Prosthetic valve endocarditis caused by Acinetobacter lwoffii: a case report and review. Cardiol Rev 14: 459.
  • 23
    Yu-Hsien L., Te-Li C., Chien-Pei C., Chen-Chi T. (2008) Nosocomial Acinetobacter genomic species 13 TU endocarditis following an endoscopic procedure. Intern Med 47: 799802.
  • 24
    Endo S., Yano H., Hirakata Y., Arai K., Kanamori H., Ogawa M., Shimojima M., Ishibashi N., Aoyagi T., Hatta M., Yamada M., Tokuda K., Kitagawa M., Kunishima H., Kaku M. (2012) Molecular epidemiology of carbapenem-non-susceptible Acinetobacter baumannii in Japan. J Antimicrob Chemother 67: 16236.
  • 25
    Kouyama Y., Harada S., Ishii Y., Saga T., Yoshizumi A., Tateda K., Yamaguchi K. (2012) Molecular characterization of carbapenem-non-susceptible Acinetobacter spp. in Japan: predominance of multidrug-resistant Acinetobacter baumannii clonal complex 92 and IMP-type metallo-β-lactamase-producing non-baumannii Acinetobacter species. J Infect Chemother 18: 5228.
  • 26
    Poirel L., Figueiredo S., Cattoir V., Carattoli A., Nordmann P. (2008) Acinetobacter radioresistens as a silent source of carbapenem resistance for Acinetobacter spp. Antimicrob Agents Chemother 52: 12526.
  • 27
    Park Y.K., Jung S.I., Park K.H., Kim S.H., Ko K.S. (2012) Characteristics of carbapenem-resistant Acinetobacter spp. other than Acinetobacter baumannii in South Korea. Int J Antimicrob Agents 39: 815.
  • 28
    Yamamoto M., Nagao M., Matsumura Y., Matsushima A., Ito Y., Takakura S., Ichiyama S. (2011) Interspecies dissemination of a novel class 1 integron carrying blaIMP-19 among Acinetobacter species in Japan. J Antimicrob Chemother 66: 24803.
  • 29
    Valentine S.C., Contreras D., Tan S., Real L.J., Chu S., Xu H.H. (2008) Phenotypic and molecular characterization of Acinetobacter baumannii clinical isolates from nosocomial outbreaks in Los Angeles County, California. J Clin Microbiol 46: 2499507.